flow. For example, changes in tissue concentration of Constriction and dilatation of large arteries regulate cerebral vascular resistance and, perhaps most imporadenosine, lactate, and tissue PO 2 , PCO 2 , and pH may contribute to increases in blood flow during increases in cere-tantly, cerebral microvascular pressure. This effect may be a protective mechanism that attenuates changes in bral metabolism. Recent findings strongly support the concept that release of nitric oxide by neurons plays a pressure in thin-walled intracranial blood vessels. There is, however, an important ''cost'' of the large proportion critical role in producing increases in blood flow during metabolic stimuli (neuronal activation) (183, 190, 191, 193 , of resistance in large cerebral arteries: the vascular bed is particularly vulnerable to a vascular ''steal.'' This con -195, 312, 315, 530, 596, 640) .
cept has been summarized previously (199) . A major mechanism that likely protects the cerebral D. Hypercapnia and Hypoxia circulation against a vascular steal is flow-mediated vasodilatation. The concept is that focal increases in blood In some vascular beds (e.g., renal, cutaneous, and flow in one region of the brain produce flow-mediated skeletal muscle), moderately severe levels of hypercapnia dilatation of large arteries upstream, and thereby protect and hypoxia have relatively small effects on blood flow against a vascular steal. The concept of flow-mediated (278). Although hypercapnia and hypoxia have a direct vasodilatation has been challenged in other vascular beds dilator effect in these vascular beds, neurohumoral stimuli (519) but appears to be especially large in magnitude and (especially the chemoreflex) produce vasoconstriction so importance in the cerebral circulation (229) . that blood flow usually fails to increase (278).
In contrast, hypercapnia and hypoxia are extremely potent vasodilators in the cerebral circulation. The vaso-III. ENDOTHELIUM-DERIVED VASOACTIVE FACTORS constrictor response to the chemoreflex is minimal in the cerebral circulation so that the direct vasodilator effects of hypercapnia and hypoxia typically produce large in-A. Nitric Oxide creases in cerebral blood flow. Recent studies suggest that cerebral vasodilatation in response to hypercapnia is 1. Nitric oxide synthases dependent on formation of nitric oxide (184, 192, 310, 313, 316, 321, 330, 523, 801) . Although formation of nitric oxide Production and release of potent vasoactive factors may contribute to mechanisms that mediate increases in by endothelium plays a major role in regulation of vascucerebral blood flow during hypoxia (28, 36, 643, 675, 749) , lar tone (Fig. 1) . Perhaps, the most important of these additional mechanisms involving formation of adenosine substances in relation to regulation of vascular tone is and activation of potassium channels may also be im-endothelium-derived relaxing factor (EDRF), the labile portant (28, 226, 412, 675, 676, 711, 750, 811) . substance which was initially described by Furchgott and Zawadski (235) in rabbit aorta. Several lines of evidence obtained in subsequent studies have led to the concept E. Autoregulation that EDRF is nitric oxide (NO) (211, 622) or a closely related compound (429, 485, 566, 684) . Although producChanges in perfusion pressure produce marked tion of NO was first described in vascular endothelium, it changes in cerebrovascular resistance and, therefore, conis now clear that NO is produced in many cells types by tribute to maintenance of relatively constant levels of a family of isoenzymes known as NO synthases (81, 224, blood flow over a wide range of pressures. Autoregulation 225, 547-549, 575, 709). seems to be particularly effective in brain, renal, and mesNitric oxide is a potent vasodilator that produces reenteric vessels and less effective in cutaneous and perlaxation of cerebral blood vessels both in vitro and in vivo haps coronary vessels (281). Mechanisms that mediate (84, 363, 484, 845) . After release by endothelium (or other autoregulation of cerebral blood vessels may include myocells), NO stimulates soluble guanylate cyclase in vascular genic responses, metabolic factors, neural mechanisms, muscle, resulting in an increase in the intracellular conand activation of potassium channels (91, 443, 638) . centration of guanosine 3,5-cyclic monophosphate (cGMP) and relaxation ( Fig. 1) (707, 800, 804) . Organic F. Flow-Mediated Vasodilatation nitrovasodilators such as nitroglycerin also produce relaxation of cerebral vascular muscle by activation of guanylate cyclase after biotransformation to NO (5, 454, 800). Large arteries play a surprisingly large role in regulation of vascular resistance in the brain (199) . Large arter-In addition to this cGMP-dependent mechanism, NO can produce relaxation of some blood vessels from some speies play a key role in regulation of the cerebral circulation, a moderate role in the coronary circulation, and little role cies via activation of potassium channels (24, 71, 130) .
All NO synthase enzymes catalyze a five-electron oxidain mesenteric and skeletal muscle circulation.
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12-02-97 15:50:37 pra APS-Phys Rev 556) . Nitric oxide reacts with superoxide anion at a rate three times faster than the dismutation of superoxide anion by superoxide dismutase (51, 53, 64, 150, 556) . Because of the efficiency of this reaction, the local concentration of superoxide dismutase may be an important determinant of activity (the biological half-life) of NO. Although formation of peroxynitrite (from interaction of NO and superoxide) has the potential to be cytotoxic, the inactivation of superoxide by NO also appears to be protective under some conditions, particularly in vivo if subsequent degradation products are nontoxic (64) . Formation of peroxynitrite is not always toxic. For example, under some physiological conditions, peroxynitrite inhibits platelet aggregation and leukocyte adhesion to endothelium (protective effects) with no evidence of cell injury (64, 444) . Thus the consequences of interaction of NO and superoxide appear to be dependent in part on FIG. 1. Some mechanisms of endothelium-dependent relaxation of cerebral vascular muscle. Nitric oxide (NO) is produced by NO synthase factors such as the presence of plasma proteins, reduced (NOS) from amino acid L-arginine (L-Arg). NO diffuses to vascular mus-thiols, and the ratio of NO to superoxide (64) . Although cle where it activates soluble guanylate cyclase, causing increased properoxynitrite can also cause relaxation of blood vessels, duction of guanosine 3,5-cyclic monophosphate (cGMP), which results in relaxation. Prostacyclin (PGI 2 ) is normally produced by cyclooxygen-the concentrations of peroxynitrite needed to produce ase-1 (COX-1) from arachidonic acid (AA). PGI 2 diffuses to vascular this effect are 50-to 1,000-fold higher than NO (53). Thus muscle where it activates adenylate cyclase, causing increased producperoxynitrite is only modestly effective as a vasodilator.
tion of adenosine 3,5-cyclic monophosphate (cAMP), which results in relaxation. Endothelium-derived hyperpolarizing factor (EDHF) is prob-Based on these biochemical characteristics, the concept ably a product of AA metabolism. EDHF diffuses to vascular muscle has emerged that NO is a protective molecule in part where it activates potassium (K / ) channels. Increased activity of potasbecause of its ability to react with and inactivate superoxsium channels produces hyperpolarization and relaxation of vascular muscle. ACh, acetylcholine.
ide anion. Relatively little is known regarding the importance of this mechanism in vivo.
tion of a guanidino nitrogen of the basic amino acid L-arginine to NO and L-citrulline ( Fig. 1) (395, 448, 621) . This process requires the presence of L-arginine (the substrate) and molecular oxygen, NADPH, tetrahydrobiopterin, flavin adenine dinucleotide, and flavin mononucleotide (225, 395, 491, 549) . Activity of NO synthases can be inhibited with analogs of L- (395, 472, 549, 599, 674, 782) . Of particular interest, ADMA is a potent inhibitor of NO synthase (196) that is produced endogenously in brain and other tissue (380, 381, 421, 777).
Inhibitors of NO synthase have been very useful in providing insight into the role of NO in the cerebral circulation. Inhibitors of soluble guanylate cyclase can also be used to examine this pathway, although inhibitors such as methylene blue may have nonspecific effects (485) Of the three isoforms of superoxide dismutase (Mn-sponsiveness to changes in shear stress, and extracellular release of NO (705, 710, 712) . superoxide dismutase, Cu/Zn-superoxide dismutase, and extracellular superoxide dismutase), extracellular superSeveral lines of evidence suggest that constitutive levels of expression of NO synthase in endothelium are oxide dismutase may be the most important in blood vessels, accounting for up to 70% of total activity of superox-sufficient to influence tone in cerebral blood vessels under basal conditions. Basal levels of cGMP are much greater in ide dismutase in some blood vessels (617, 618, 738) . The distribution of extracellular superoxide dismutase in the cerebral arteries with endothelium than in vessels without endothelium (143, 171, 378, 743, 767) . Inhibitors of NO vessel wall seems ideal for protection from superoxide anion, because NO diffuses from endothelium through synthase decrease basal levels of cGMP and produce contraction of cerebral arteries in vitro that is endothelium vascular muscle (617, 618) . Inactivation of NO by superoxide anion may contribute to impaired NO-mediated dilata-dependent (17, 143, 171, 541, 771). Inhibitors of NO synthase also produce constriction of cerebral blood vessels tion of cerebral blood vessels under pathophysiological conditions in which reactive oxygen species are pro-and decrease cerebral blood flow under basal conditions in several species including nonhuman primates (25, 32, duced. Production of superoxide anion has been reported to occur in brain in response to acute hypertension (814), 151, 156, 158, 160, 161, 183, 186, 187, 190, 191, 196, 198, 200, 258, 310, 312, 313, 321, 331, 382, 422, 423, 476 , 523-seizures (30, 47), fluid-percussion injury (359, 410, 765) , and perivascular blood (535), as well as during meningitis 526, 620, 642, 673, 687, 708, 746, 754, 764, 768, 783) . This same effect has been observed in midgestation, indicating (446, 520) , ischemia with reperfusion (29, 409, 578), and during asphyxia with reventilation (664, 665) .
that the influence on NO in the cerebral circulation may begin early in development (403, 595). Reductions in cereThree isoforms of NO synthase, which are products of separate genes, have been identified. Based on the cell bral blood flow in response to L-NNA are absent in mice that are deficient in expression of the gene for endothelial type from which they were initially identified, these three isoforms are frequently described as neuronal, inducible NO synthase (38, 470, 471) , suggesting that endothelium is the primary source of NO that influences basal tone. (initially identified in macrophages), and endothelial NO synthase (81, 225, 548, 549, 832) . Numerical nomenclature,
In contrast to constriction of cerebral blood vessels in response to inhibitors of NO synthase, exogenous adbased on the historical order of enzyme purification and gene cloning, is also used. Nitric oxide synthase I (NOS ministration of L-arginine, the substrate for NO synthase, has been frequently found to have no effect on cerebral I), NOS II, and NOS III are sometimes used to describe isoforms initially isolated from neurons, macrophages, vascular tone (194) . Even at relatively high concentrations, L-arginine does not affect tone of cerebral arteries and endothelium, respectively (111, 225, 245, 395, 469, 484, 549, 588) .
or arterioles in vitro (17, 382, 583), cerebral arterioles (32, 46, 187, 673, 815 ) and the basilar artery in vivo (186, 187, 386, 505) , or cerebral blood flow (197, 198, 258, 275, 422) .
Nitric oxide synthase in endothelium
These findings suggest that availability of L-arginine is not rate limiting for activity of NO synthase in cerebral Expression of NO synthase in endothelium (NOS III) is controlled by a single gene (96, 225, 248, 341, 433, 484 , endothelium. This finding is not surprising because the Michaelis constant (half-saturating concentration of L-ar-862). The promoter for endothelial NO synthase, like that of other housekeeping genes which are expressed consti-ginine) value for L-arginine for endothelial NO synthase is Ç3 mM (224, 225) , and levels of L-arginine in plasma tutively, does not contain a TATA-like element (225, 540). Endothelial NO synthase also contains a shear stress re-and endothelium are in the range of 100-2,200 mM (68, 225, 277, 342, 822) . In contrast to these studies, which sponse element in its promoter region (225, 540, 588, 789) . Messenger RNA and protein for NO synthase are present indicate that L-arginine has no significant effect on tone of cerebral vessels, some studies have reported very small in normal cerebral endothelium (82, 108, 159, 234, 253, 330, 483, 660, 661) . Protein for NO synthase can be de-to moderate levels of vasodilatation in brain in response to L-arginine (94, 261, 351, 352, 552, 553, 620, 678, 687) . tected in cerebral endothelium relatively early in gestation (543, 594) .
Activity of NO synthase in endothelium, and NO synthase in neurons (NOS I), is dependent on the presence Immunocytochemistry and measurements of enzyme activity indicate that NO synthase is found predominantly of calcium (395, 549) . Basal activity of NO synthase can be further stimulated by increases in intracellular calcium in the particulate fraction of endothelium (225, 234, 705) . Myristoylation and palmitoylation of the enzyme are es-in response to receptor-mediated agonists ( Fig. 1) (337) . Lee (442) first demonstrated that acetylcholine produces sential for localization of NO synthase to plasmalemmal caveolae (218, 239, 712) . Caveolae are plasmalemmal mi-endothelium-dependent relaxation of cerebral arteries. It is now known that many substances, in addition to acetylcrodomains where signaling molecules appear to be concentrated. Localization of endothelial NO synthase in ca-choline, produce endothelium-dependent relaxation of cerebral vessels (188) , which is dependent on production of veolae may be critical for optimal enzyme function, re-gene which encodes COX-1 (like endothelial NO synthase) ence vascular tone. Messenger RNA for COX-2 is expressed in cerebral microvessels in response to lipopolydoes not contain a TATA-like element and thus has one characteristic of a housekeeping gene (726).
saccharide (104) and interleukin-1b (105), and interleukin-1 increases production of prostacyclin in cerebral endoCyclooxygenase-2 is an inducible isoform that is expressed primarily in macrophages, fibroblasts, endothe-thelium (513) . Interleukin-1 produces dilatation of cerebral arterioles in newborn pigs that is inhibited by indolium, and vascular muscle (327, 726, 828) . Although it is characterized as an inducible isoform (and is undetectable methacin (715) and presumably mediated by activation of COX-2. in most mammalian tissues under normal conditions), COX-2 is expressed constitutively in some organs including brain (726). Many of the same stimuli that result in C. Endothelium-Derived Hyperpolarizing Factor expression of inducible NO synthase also stimulate expression of COX-2 (458, 537, 821, 828). These stimuli include lipopolysaccharide, adenosine 3,5-cyclic monoIn addition to production and release of NO and prostacyclin, endothelium may also produce relaxation of phosphate (cAMP), hypoxia, and some cytokines, growth factors, and hormones (80, 327, 706, 828) . Expression of underlying vascular muscle by release of endotheliumderived hyperpolarizing factor(s) (EDHF) (55, 130, 241, COX-2 is involved in inflammation (537, 828) and may be the predominate source of prostaglandins under these 574) (Fig. 1) . In large cerebral arteries, for example, acetylcholine, substance P, and bradykinin produce endotheconditions (458). Under basal conditions in adult rats, COX-2 is undetectable using in situ hybridization in cere-lium-dependent hyperpolarization and relaxation of vascular muscle (77, 142, 546, 590, 648, 740 ), which appears bral vessels (104). In contrast, under normal conditions in newborn pigs, the predominant source of prostaglan-to be mediated, in part, by an EDHF. Although EDHF is more difficult to bioassay than EDRF, recent evidence dins in cerebral vessels appears to be COX-2 (644). Messenger RNA levels for COX-1 and COX-2 increase in brain indicates that EDHF is a diffusible (transferable) factor that causes relaxation by hyperpolarizing underlying vasin response to ischemia (133, 296, 593, 607, 656), after systemic administration of lipopolysaccharide (80), and cular muscle (118, 130, 546, 662) . The importance of EDHF as a mediator of endothelium-dependent relaxation has in response to Borna disease virus (554) . Expression of COX-2 is also increased in brain for prolonged periods of been reported to increase as vessel size decreases (216, 718) . For example, expression of endothelial NO synthase time after repeated episodes of cortical spreading depression (99). and the importance of NO have been reported to decrease, and the importance of EDHF increase, as vessels become Prostacyclin is a powerful inhibitor of platelet aggregation ( Fig. 1) (829) . In addition, prostacyclin and stable smaller in the mesenteric circulation (718) .
The identity of EDHF remains a subject of debate prostacyclin analogs produce relaxation of cerebral arteries in vitro and cerebral arterioles in vivo (25, 178, 226, and investigation. In some extracranial arteries, NO (sometimes only at relatively high concentrations) pro-371, 612, 613, 688, 766, 779, 799) (Fig. 1) . Relaxation of cerebral vessels in response to prostacyclin is generally duces hyperpolarization of vascular muscle and thus may function as an EDHF (130). Nitric oxide and donors of NO thought to be endothelium independent (371, 688, 766) but may be mediated by more than one mechanism. Relax-like 3-morpholinosydnonimine (SIN-1) produce marked relaxation but have little or no effect on membrane potenation of cerebral vessels in response to prostacyclin may be mediated by activation of adenylate cyclase with accu-tial in large cerebral arteries (77, 563, 658, 659) . The absence of hyperpolarization suggests that NO is not an mulation of cAMP (626, 762) (Fig. 1) and activation of potassium channels (141, 226) . In contrast, recent findings EDHF in these blood vessels. In contrast, NO produces glibenclamide-sensitive hyperpolarization of the guinea in the newborn pig suggest that dilatation of cerebral arterioles in response to prostacyclin is partially dependent pig carotid artery, suggesting that the response is mediated by ATP-sensitive potassium channels (141). Because on formation of NO (25).
Factors that regulate COX gene expression and pro-relaxation of cerebral blood vessels in response to prostacyclin is antagonized by inhibitors of potassium channels duction of prostacyclin in cerebral endothelium are not well defined. Several stimuli, including bradykinin, throm-in some cerebral blood vessels (41, 141, 226), prostacyclin may also act as an EDHF in the cerebral circulation. bin, and A-23187, increase prostacyclin production in cerebral arteries and cultured cerebral endothelium (513, In many arteries, however, it seems clear that EDHF is not NO or a prostanoid, because inhibitors of NO syn-550, 610, 834). Endothelium-dependent relaxation of human cerebral arteries in response to 4-hydroxynonenal, thase and COX do not attenuate endothelium-dependent hyperpolarization or relaxation of vascular muscle (118, and acetylcholine-induced relaxation of the vertebral artery from newborn humans, is inhibited by indomethacin 130, 142, 574). A substantial body of evidence, obtained primarily from studies of coronary blood vessels, suggests and thus may be mediated by prostacyclin (112, 487).
Expression of COX-2 in cerebral vessels may influ-that an EDHF is a product of cytochrome P-450 monooxy-
12-02-97 15:50:37 pra APS-Phys Rev Epoxyeicosatrienoic acids are produced in brain (19, ation of P-450 metabolites unless these metabolites subsequently act as substrate for COX as described for 5,6-177, 244, 267) and by astrocytes (16), and some epoxyeicosatrienoic acids produce relaxation of cerebral blood ves-epoxyeicosatrienoic acid (177).
Hyperpolarization of vascular muscle in response to sels (19, 177, 244) . For example, both 5,6-epoxyeicosatrienoic acid and 11,12-epoxyeicosatrienoic acid produce re-EDHF is most likely mediated by activation of potassium channels (102, 130, 241, 546, 662) (Fig. 1) . For example, laxation of the middle cerebral artery in vitro (244). Consistent with a possible function as EDHFs, 11,12-ep-relaxation of cerebral vessels in response to acetylcholine appears to be mediated, in part, by production of an EDHF oxyeicosatrienoic acid produces relaxation of the middle cerebral artery, which is inhibited by a high concentration that activates ATP-sensitive potassium channels (77, 192, 740) . Activation of calcium-dependent potassium chanof tetraethylammonium (TEA) ion (244), and 14,15-epoxyeicosatrienoic acid enhances an outward potassium cur-nels may also mediate EDHF-induced relaxation in some arteries (117, 118, 130, 662) , including the canine carotid rent in smooth muscle isolated from cerebral microvessels (16). In contrast, 5,6-epoxyeicosatrienoic acid (but artery (546) . Charybdotoxin, an inhibitor of calcium-dependent potassium channels, produces partial inhibition not 11,12-epoxyeicosatrienoic acid) is a potent dilator of cerebral arterioles in vivo (19, 177). Interestingly, effects of relaxation of the middle cerebral artery in response to acetylcholine (817). Endothelium-dependent hyperpolarof 5,6-epoxyeicosatrienoic acid on cerebral arterioles were inhibited by indomethacin or by superoxide dismu-ization, which is not mediated by NO, has been described in human cerebral arteries in response to substance P tase plus catalase (177), suggesting 5,6-epoxyeicosatrienoic acid does not directly produce relaxation in cerebral (648).
The role of cytochrome P-450 monooxygenase mearterioles. It is known that 5,6-epoxyeicosatrienoic acid can be metabolized by COX, resulting in formation of tabolites as possible EDHFs has been supported, in part, by the use of cytochrome P-450 inhibitors. Although there reactive oxygen species that mediate vasodilatation (177).
Although it seems clear that some epoxyeicosatrie-is evidence that these inhibitors abolish release of EDHF from endothelium (662) , high concentrations of these noic acids produce relaxation of cerebral blood vessels, little is known whether these substances are produced compounds may also exert nonspecific effects (173, 216).
For example, some inhibitors of P-450 including clotrimaby cerebral endothelium and function as EDHFs in the cerebral microcirculation. A recent study suggests that zole have been reported to directly inhibit activation of potassium channels (independent of effects on activity of release of cytochrome P-450 products by endothelium contributes to dilatation of cerebral microvessels during P-450 enzymes) (173, 871). Thus interpretation of results obtained with these agents may need to be made with hypoxia in newborn pigs (445). In the carotid artery, acetylcholine causes release of an EDHF that may be a prod-caution (173).
In contrast to studies that implicate a role for EDHFs uct of cytochrome P-450 monooxygenase metabolism (44, 456). Interestingly, bioassay studies suggest that NO inhib-in regulation of vascular tone, several studies suggest that activation of potassium channels does not contribute to its the formation and/or release of EDHF in this artery (45). The implication of this finding is that when activity relaxation of cerebral vessels in response to endotheliumdependent vasodilators in vitro and in vivo (17, 78, 200, of NO is reduced, such as under pathophysiological conditions, synthesis or release of EDHF may increase as a 631, 751, 817). Thus the overall functional importance of EDHF in cerebral vessels is not clear. compensatory mechanism. In contrast to these findings, endothelium-dependent hyperpolarization in the carotid artery of the guinea pig does not appear to be a product D. Endothelin of cytochrome P-450 monooxygenase, COX, or lipoxgenase and thus may not be a product of arachidonic acid metabolism (142).
In addition to relaxing factors, endothelium can release substances that produce contraction of blood vesStudies of coronary blood vessels that have implicated cytochrome P-450 monooxygenase metabolites as sels. The endothelium-derived contracting factor (EDCF) that has received the most investigation is endothelin, a potential EDHFs have frequently used arachidonic acid as a stimulus to produce endothelium-dependent relax-peptide originally isolated from aortic endothelium (840) (Fig. 3 ). There are three isopeptides of endothelin, all ation. In contrast to coronary arteries (102), dilatation of cerebral arterioles in several species in response to 21 amino acids, that are the products of separate genes thelin-B receptors are expressed in smooth muscle in some blood vessels and mediate contraction (Fig. 3) . In contrast, activation of ET B receptors (which are commonly expressed in endothelium) produces relaxation of blood vessels through release of prostacyclin or EDRF (257, 290, 692, 774) (Fig. 3) . Some studies suggest there may be two distinct subtypes of ET B receptors (receptors that produce vasorelaxation or vasoconstriction) (806).
Endothelin-1 produces potent and long-lasting contraction of cerebral vessels both in vivo and in vitro (1, 2, 14, 31, 152, 185, 212, 217, 219, 265, 338, 390, 600, 625, 632, 680, 697, 698, 701, 757, 820) . Endothelin-1 and ET-2 are much more potent than ET-3 in producing contraction (698, 701 B receptors produces marked relaxation of cerebral vessels acids), which are converted by endopeptidases to propeptides (also known as big endothelins). For example, pre-that is mediated by NO (390, 391, 634, 702) . Sarafotoxin 6c (a selective agonist for ET B receptors) produces relaxpro-ET-1 is cleaved to big ET-1, which is then converted to ET-1 by endothelin-converting enzyme (255, 692) (Fig. ation of human cerebral arteries, suggesting that ET B -mediated relaxation can also be induced in human vessels 3). Endothelin-converting enzymes (ECE-1 and ECE-2) are metalloproteases that are associated with the mem- (586) . Application of inhibitors of ET A , or both ET A and ET B , receptors has no effect on tone of cerebral vessels brane fraction of cells (255, 257, 785, 803) .
Cerebral endothelium can produce endothelin under in vivo, which suggests that production of endothelin does not contribute to basal tone in the cerebral circulation some conditions. Of the three isopeptides, only ET-1 is produced normally by endothelium (692), and mRNA for (249, 632-634, 869, 870) . ET-1 can be detected in cerebral endothelium (848). Messenger RNA for ECE-1 has also been detected in cerebral E. Other Endothelium-Derived Vasoactive Factors endothelium using in situ hybridization (833) . Endothelin gene expression can be enhanced by several factors in-1. Reactive oxygen species cluding thrombin, transforming growth factor-b, hemoglobin, and tumor necrosis factor-a (181, 605, 692) and can
In addition to the factors described above, cerebral endothelium may produce several additional vasoactive be inhibited by NO and cGMP (76, 165, 255, 692). A shear stress response element is present in the promoter of the substances including reactive oxygen species, carbon monoxide, and nonendothelin EDCFs. For example, al-ET-1 gene, but in contrast to the gene for endothelial NO synthase, activation of this element decreases transcrip-though bradykinin produces NO-dependent relaxation of the basilar artery and the middle cerebral artery (254, 363, tion of the ET-1 gene (692).
Endothelins are known to mediate effects in blood 417, 494, 541, 614), another mechanism mediates bradykinin-induced dilatation of pial arterioles that supply the vessels through activation of two receptors, endothelin-A (ET A ) and endothelin-B (ET B ) receptors, which have been cerebrum. In these microvessels, dilatation in response to bradykinin is endothelium dependent but mediated by cloned (23, 255, 700). In general, ET A receptors are expressed in vascular muscle and mediate contraction to reactive oxygen species (either hydroxyl radical or hydrogen peroxide depending on the species) (414, 415, 683, endothelin (257) (Fig. 3) .
The response to activation of ET B receptors on vascu-844). Reactive oxygen species are dilators in the cerebral microcirculation of several species (409, 413, 417, 682, lar tone depends on localization of the receptor. Endo-
12-02-97 15:50:37 pra APS-Phys Rev 778, 809, 812, 844, 845). As discussed in section VB, dilatation of cerebral microvessels in response to bradykinin appears to be mediated by activation of potassium channels (208).
Carbon monoxide
Recent evidence suggests that carbon monoxide might also function as an EDRF in some blood vessels (853). Carbon monoxide is produced from heme by two isoforms of heme oxygenase (HO-1 and HO-2) (478), and HO-2 is expressed constitutively in endothelium of cerebral arteries (853). The functional significance of carbon monoxide as a regulator of tone in cerebral vessels is unclear however. Carbon monoxide produces relaxation of some blood vessels, including the aorta, but does not produce direct (790), which provides addi-clase, resulting in increased production of cGMP and relaxation. tional evidence that carbon monoxide may not function as a direct dilator in cerebral blood vessels. Although carbon monoxide may not directly relax cerebral vessels, recent conditions, contracting substances that are not endothelin evidence obtained in neurons suggests that carbon monox-may be produced by cerebral endothelium. These EDCFs ide may modulate formation of cGMP in response to NO are primarily metabolites of arachidonic acid produced (326). Thus carbon monoxide may influence cerebral vas-through the COX pathway (366), which produce contraccular tone indirectly via effects on production of cGMP in tion by activation of PGH 2 -thromboxane A 2 receptors smooth muscle in response to NO.
(144) (Fig. 4) . Superoxide anion, which is also produced via the COX pathway, produces contraction of the canine 3. Other endothelium-derived constricting factors basilar artery, and thus may be an EDCF under some conditions (144), although recent evidence suggests conIn some cerebral arteries such as the canine basilar traction to superoxide anion is due to inhibition of basal artery, and in the presence of some pathophysiological effects of NO (362) (Fig. 4) . Endothelium-dependent contraction may occur in response to A-23187 (144, 367, 369, 720), xanthine plus xanthine oxidase (which generates reactive oxygen species) (365), hydrogen peroxide (365), acetylcholine (344, 367, 379, 780) , arachidonic acid (379, 780), anoxia (368), angiotensins (480) , nicotine (719) , and phospholipase A 2 (571).
IV. INDUCIBLE NITRIC OXIDE SYNTHASE
In contrast to endothelial NO synthase (NOS III), which is expressed constitutively, an inducible or ''immunologic'' isoform of NO synthase (NOS II) can be expressed in many cells types including vascular muscle and endothelium (113, 245, 335, 357, 358, 426, 434, 477, 548 of inducible NO synthase is regulated primarily at the sion for interleukin-10 suggest that endogenous interleukin-10 is a major regulator of expression of inducible NO level of gene expression (548, 556, 575, 598) .
Inducible NO synthase produces much greater synthase (206). Inhibitors of tyrosine kinase and glucocorticoids also block expression of inducible NO synthase amounts of NO than the constitutive forms of NO synthase (endothelial and neuronal NO synthase) (395, 426, 548) . (225, 575, 670) . Expression of the inducible NO synthase in vascular muscle is dependent on binding of nuclear Because high concentrations of NO can be toxic to cells, either alone or in combination with superoxide ion that factor kB to the promoter (737) and can be blocked by inhibition of activation of nuclear factor kB (737, 831). As produces peroxynitrite (53) (Fig. 2) , inducible NO synthase is often referred to as the ''pathological'' form of described previously for endothelial NO synthase, NO may modulate the level of gene expression for inducible NO synthase (426, 548, 576, 707) . Once formed from NO and superoxide, peroxynitrite may be protonated to yield NO synthase via a negative-feedback mechanism (132, 628, 629) . For example, NO inhibits expression of induchydroxyl radical, which is extremely reactive (51, 53, 120, 150). Thus, in addition to its direct effects, formation of ible NO synthase in human microglia through a mechanism that may involve decreased availability of nuclear NO may contribute to formation of toxic reactive species such as hydroxyl radical (Fig. 2) .
factor kB (132 (225, 395) . Lipopolysaccharide also in-mors (127). Protein for inducible NO synthase is present in cerebral vascular muscle and infiltrating leukocytes duces mRNA for arginase II (256). Activity of arginase II may play a major role in production of NO by influencing after traumatic brain injury (124). mRNA for inducible NO synthase can be detected in meninges and choroid plexus the availability of L-arginine, the substrate for NO synthases.
after systemic administration of lipopolysaccharide (826) . Recent studies suggest that NO may modulate permeabilIt is noteworthy that mRNA for interleukin-1b converting enzyme and other genes that encode the interleu-ity of the blood-brain barrier (504) , and expression of inducible NO synthase may contribute to increased perkin-1 system appear to be expressed constitutively in cerebral microvessels (825) . Expression of this ''vascular in-meability of the blood-brain barrier after exposure to lipopolysaccharide (69, 721). terleukin-1 system'' may contribute to regulation of expression of inducible NO synthase and COX-2.
Although expression of inducible NO synthase has generally been found to be associated with inflammatory or pathoExpression of inducible NO synthase can be inhibited by several factors including interleukin-4, interleukin-10, physiological conditions, it appears that the gene may be active during development. For example, mRNA and protein transforming growth factor-b, basic fibroblast growth factor, aldosterone, heat shock protein 70, and insulin-like for inducible NO synthase have been detected in parenchymal microvessels in brain during normal embryonic development growth factor (50, 131, 213, 225, 323, 645, 704) (Fig. 5) . Preliminary experiments in mice that lack gene expres-and in newborn rats (238). Inducible NO synthase is not
12-02-97 15:50:37 pra APS-Phys Rev found in vessels in immature or adult animals under normal conditions (124, 238), and the significance of vascular expression of this isoform of NO synthase during early life is not clear. Because NO can influence vascular growth, we speculate that expression of inducible NO synthase early in ontogeny may contribute to vascular remodeling. Recent evidence suggests that lipopolysaccharide and tumor necrosis factor-a cause expression of inducible NO synthase that affects cerebral vascular tone in vivo (83, 85, 86, 561, 593) . Lipopolysaccharide causes marked, progressive dilatation of cerebral arterioles and increases in levels of cGMP in perivascular cerebrospinal fluid that are attenuated by inhibitors of NO synthase, including L-NMMA and aminoguanidine (85, 86 ). Aminoguanidine appears to be a relatively selective inhibitor of inducible NO synthase (536, 736, 824) and, at appropriate concentra- Changes in activity of potassium channels represent a major mechanism that regulates vascular tone. Activation of potassium channels in vascular muscle produces hyperpolarization of the cell membrane, closure of voltage-dependent calcium channels, a decrease in intracellular calcium, and vascular relaxation (387, 579, 582) ( based studies have provided evidence that several types of nels, which are present in cell membrane, can be activated by several stimuli including receptor-mediated agonists, increases in cAMP, hyp-potassium channels are present in cerebral blood vessels oxia, and reductions in intracellular ATP. These channels can also be (387, 582). Although the majority of studies have focused activated by synthetic compounds including cromakalim and aprikalim.
on potassium channels in vascular muscle, potassium ATP-sensitive potassium channels can be inhibited with glibenclamide.
When potassium channels open, potassium exits the cell. This efflux of channels can also be expressed in endothelium (115, 431, potassium ions hyperpolarizes the cell membrane, resulting in closure 465, 466) . In endothelium, membrane hyperpolarization of voltage-gated calcium (Ca 2/ ) channels, reductions in intracellular levels of calcium, and relaxation.
causes mobilization of calcium and may be an important
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and cerebral arterioles in response to nitrovasodilators (192, 200, 332, 412, 750) and relaxation of the carotid A. ATP-Sensitive Potassium Channels artery in response to acetylcholine and sodium nitroprusside (205) are not inhibited by glibenclamide. In newborn pigs, glibenclamide has been reported to have no effect Adenosine 5-triphosphate-sensitive potassium channels have been described in vascular muscle, including (40, 445) and to inhibit cerebral vasodilatation in response to nitroprusside (26). cerebral vessels (392, 582, 740). These potassium channels are defined based on sensitivity to intracellular ATP, Although it is well known that hypoxia produces marked increases in cerebral blood flow, mechanisms that which inhibits activity of the channel (582) (Fig. 6 ). Dissociation of ATP from the channel results in channel open-mediate this response have been elusive. Several recent studies suggest that activation of ATP-sensitive potassium ing and hyperpolarization. In contrast to intracellular ATP, other factors including reductions in PO 2 or pH open the channels is an important mechanism that contributes to cerebral vasodilation during hypoxia (Fig. 6 ). Relaxation channels and produce vasorelaxation (579, 582). These properties support the concept that activity of ATP-sensi-of the carotid artery (749), large cerebral arteries (226) , and cerebral arterioles (711, 750) in response to hypoxia tive potassium channels may, in part, reflect the metabolic state of cells (579).
is inhibited by glibenclamide. Increases in cerebral blood flow during hypoxia are attenuated by glibenclamide and Electrophysiological and pharmacological studies of cerebral vascular muscle indicate that ATP-sensitive po-tolbutamide, another inhibitor of ATP-sensitive potassium channels (675, 676) . Activation of ATP-sensitive potastassium channels are activated by synthetic compounds including cromakalim (or levcromakalim) and aprikalim sium channels is also one of several mechanisms that may contribute to autoregulatory responses of cerebral (392, 569, 740) (Fig. 6 ). Activity of these channels is inhibited by sulfonylureas including glibenclamide (392, 582, arterioles during hypotension (443) and relaxation of cerebral arteries in response to acidosis (383). 657, 740) (Fig. 6 ). Glibenclamide appears to be a selective inhibitor of ATP-sensitive potassium channels at the most Although activation of ATP-sensitive potassium channels appears to be an important mechanism during cerecommonly used concentrations (õ3 mM) and has been used frequently to examine the role of ATP-sensitive po-bral vasodilatation in response to several stimuli, these channels do not appear to influence resting tone in the tassium channels in intact cerebral vessels.
Activators of ATP-sensitive potassium channels pro-cerebral circulation. In both the basilar artery (200, of glibenclamide has no effect on vessel tone. Intraparen-758, 817, 861), including human arteries (282, 648) in vitro. These activators of ATP-sensitive potassium channels also chymal tolbutamide has no effect on local cerebral blood flow (675) . cause dilatation of the basilar artery (200, 389, 499, 569, 729, 732, 770) and cerebral arterioles in vivo (26, 40, 41, Some progress has been made recently regarding the molecular biology of ATP-sensitive potassium channels 201, 297, 332, 412, 443, 445, 507, 711, 750, 751, 770, 796, 797) . Intraparenchymal injection of cromakalim produces (739). The channel is a heteromultimer composed of poreforming subunits (typically of inward-rectifying potassium a glibenclamide-sensitive increase in local cerebral blood flow (675) . Thus ATP-sensitive potassium channels are channels) and sulfonylurea receptor subunits (667) . The sulfonylurea receptor (which in itself cannot form a chanpresent and functional in the cerebral circulation. Some evidence suggests that the distribution of ATP-sensitive nel; Ref. 18) has been cloned (4). Subsequent cloning of ion-permeable subunits (739) has allowed coexpression potassium channels in cerebral vessels is heterogeneous and varies with vessel size and brain region (522, 569) .
of the sulfonylurea receptor with an inward-rectifying subunit to form a channel that exhibits many properties of Several endogenous substances produce hyperpolarization and relaxation of cerebral vascular muscle that native ATP-sensitive potassium channels (259). It is also interesting to note that the sulfonylurea receptor can couappears to be mediated by activation of ATP-sensitive potassium channels. These substances include EDHF ple to different types of inwardly rectifying potassium channels (18). This characteristic may confer sensitivity (77), vasoactive intestinal polypeptide (740), calcitonin gene-related peptide (CGRP) (297, 298, 339, 388, 392, 463, to glibenclamide in potassium channels that are not ATP sensitive (18). Thus the presence of glibenclamide sensi-581, 696, 740), adrenomedullin (436) , prostacyclin (41, 226), opioids (711) , norepinephrine (via b-adrenergic re-tivity does not necessarily indicate the presence of ATPsensitive potassium channels (667) . To what extent this ceptors) (385), cAMP (385), and adenosine (28, 392, 569).
Although NO may produce relaxation of some vessels ''promiscuous'' coupling between the sulfonylurea receptor and inward rectifier potassium channels occurs in via activation of potassium channels, most studies suggest
12-02-97 15:50:37 pra APS-Phys Rev blood vessels is not clear. In coronary vascular muscle, sium channels have no effect on vessel diameter in vivo (27, 298, 436, 636, 751, 813) or produce very modest vasothe sulfonylurea receptor appears to be very predominantly associated with the appropriate subunit or subunits constriction (751) . Thus the influence of calcium-dependent potassium channels on basal tone may be more imto form ATP-sensitive potassium channels (818). In cerebral arteries, it is noteworthy that a high concentration portant in large cerebral arteries than in cerebral arterioles. of glibenclamide (10 mM) has been reported to have no effect on currents carried by inward-rectifier potassium
In addition to influencing basal tone of large cerebral arteries, activation of calcium-dependent potassium chanchannels (668) . nels appears to be an important mediator of vasodilatation in response to several stimuli. Dilatation of cerebral arteri-B. Calcium-Dependent Potassium Channels oles in response to forskolin (a direct activator of adenylate cyclase), cAMP, isoproterenol (a b-adrenergic agonist that activates adenylate cyclase), CGRP, and adrenomedCalcium-activated potassium channels have been described in vascular muscle, including muscle from cere-ullin is attenuated by inhibitors of calcium-dependent potassium channels (27, 298, 436, 507, 636, 751) . Isoproterebral vessels (79, 247, 295, 579, 582, 734). These potassium channels are defined based on their activation by in-nol, forskolin, and cAMP all increase activity of calciumdependent potassium channels in cerebral vascular muscreases in the concentration of intracellular calcium (Fig.  7) . Activity of calcium-activated potassium channels in-cle, as demonstrated with patch-clamp methodology (734). Thus adenylate cyclase-mediated activation of calcreases with membrane depolarization (79, 247, 580, 582) and can be affected by other vasoactive stimuli.
cium-dependent potassium channels may be an important mechanism of vasodilatation ( Fig. 7 ). This mechanism Calcium-activated potassium channels consist of aand b-subunits (346) . The a-subunit is a member of the may play a major role in regulation of cerebral vascular tone, since cAMP in vascular muscle increases in response slowpoke (slo) potassium channel gene family. The asubunit forms the ion conduction pore of the channel to a variety of stimuli including adenosine, prostacyclin, CGRP, vasoactive intestinal polypeptide, pituitary adenyl- (346) , and this subunit has been cloned from vascular muscle in humans (hslo) (514) . A b-subunit of calcium-ate cyclase activating peptide, and adrenomedullin (22, 168, 169, 174, 304, 339, 398, 572, 585) (Fig. 7) . In addition dependent potassium channels has also been cloned and is expressed at high levels in aorta (773). This b-subunit to these stimuli, relaxation of the middle cerebral artery to hypoxia and 11,12-epoxyeicosatrienoic acid, a product is a membrane-spanning protein that appears to act as a regulatory component of the channel (346) . Coexpression of P-450 metabolism of arachidonic acid in brain, is inhibited by TEA ion and thus may be mediated by activation of the hslo gene cloned from vascular muscle with the b-subunit in Xenopus oocytes results in a channel that of calcium-dependent potassium channels (243, 244).
It is important to note that NO may activate calciumexhibits many of the properties of calcium-activated potassium channels (calcium sensitivity; inhibition by TEA dependent potassium channels in some (24, 130, 679, 846), but not all (514), blood vessels (Fig. 7) . The functional ion and iberiotoxin) (514) . Little is known at present regarding factors that regulate expression of genes that en-importance of this mechanism seems to vary with vessel size, species, and tissue (130). In the rat, dilatation of code a-and b-subunits of calcium-activated potassium channels in vascular muscle.
cerebral arterioles in response to nitroprusside and 8-bromo-cGMP (a cGMP analog) is inhibited by TEA ion and In comparison with activators of ATP-sensitive potassium channels, development of selective pharmacological iberiotoxin (636) . Thus activation of calcium-dependent potassium channels may be an important mediator of reactivators of calcium-dependent potassium channels has been slow. NS-1619 produces relaxation of cerebral arter-laxation in response to NO and cGMP in cerebral microvessels (636) (Fig. 7) . ies that appears to involve opening of calcium-dependent potassium channels in vascular muscle (295). However, In contrast, inhibitors of calcium-dependent potassium channels do not attenuate relaxation of rabbit cerethis compound has other vasoactive effects including inhibition of calcium channels (295, 439). Activity of calcium-bral arterioles (751) or large cerebral arteries from the rabbit and rat (732, 817) in response to nitrovasodilators activated potassium channels can be inhibited with TEA ion, charybdotoxin, and iberiotoxin (247, 387, 582) ( These findings are consistent with the observation that 7). Of these inhibitors, iberiotoxin appears to be highly selective, with no known nonspecific effects (387, 582) .
NO and SIN-1 do not hyperpolarize vascular muscle in large cerebral arteries (77, 563, 658, 659). One interpretaIn cerebral arteries, application of inhibitors of calcium-activated potassium channels produces contraction tion of these findings is that NO does not activate calciumdependent potassium channels in some cerebral blood in vitro (34, 35, 79, 250) and in vivo (229) , suggesting that these channels are active under basal conditions. In vessels. An alternative interpretation is that NO activates these potassium channels in cerebral vessels, but that NO cerebral arterioles, inhibitors of calcium-dependent potas-
12-02-97 15:50:37 pra APS-Phys Rev that is released under basal conditions activates calciumVoltage-dependent potassium channels can be inhibited fairly selectively by 4-aminopyridine (582). 4-Aminodependent potassium channels. Under these conditions, additional NO (applied exogenously or formed endoge-pyridine is often used to distinguish calcium-dependent from voltage-dependent potassium channels; both channously) may not produce further activation of potassium channels. The finding that nitrovasodilators produce nels are activated by membrane depolarization. Activity of voltage-dependent potassium channels can also be inmembrane hyperpolarization in the endothelium-denuded basilar artery (563) is consistent with this possibility.
hibited by cesium ion and high concentrations of TEA or glibenclamide (582) . Recent electrophysiological studies suggest that reactive oxygen species may relax blood vessels via activation Relatively little is known about the physiological importance of these potassium channels in the cerebral cirof potassium channels. For example, hydrogen peroxide and oxidizing agents such as 5,5-dithio-bis(2-nitrobenzoic culation. Like calcium-dependent potassium channels, activity of voltage-dependent potassium channels may conacid) and oxidized glutathione increase activity of calcium-dependent potassium channels in vascular muscle tribute to regulation of membrane potential and responses of cerebral arteries to changes in arterial pressure (393). (425, 627) . Dilatation of cerebral arterioles in response to hydrogen peroxide and bradykinin is attenuated by TEA One would anticipate that these voltage-dependent potassium channels may limit vasoconstrictor responses to and iberiotoxin (208), suggesting that the response is mediated by activation of calcium-dependent potassium other stimuli that depolarize vascular muscle. Because reduction of intracellular pH increases the current carried channels. Dilatation of cerebral arterioles in response to bradykinin is mediated by reactive oxygen species (either by voltage-dependent potassium channels, it has been suggested that these channels may be important in mediation hydroxyl radical or hydrogen peroxide depending on the species) (414, 415, 683, 844). Cerebral vasodilatation in of cerebral vasodilatation during acidosis and/or hypercapnia (72). In pulmonary vascular muscle, NO has been response to hydrogen peroxide and peroxynitrite may be inhibited by glibenclamide, and thus mediated by ATP-reported to activate voltage-dependent potassium channels (852). 4-Aminopyridine partially inhibits hyperpolarsensitive potassium channels, in some species (813). Thus activation of potassium channels appears to be a major ization and relaxation of these arteries in response to NO, which is consistent with activation of these potassium mechanism of relaxation of cerebral vessels in response to reactive oxygen species. channels by NO (846, 852). It is not known whether a similar mechanism contributes to NO-mediated relaxation Some endogenously produced substances may influence membrane potential of vascular muscle and produce of cerebral blood vessels. constriction of cerebral vessel by inhibitory effects on calcium-dependent potassium channels. For example, ce-D. Inward-Rectifier Potassium Channels rebral microvessels can produce 20-hydroxyeicosatetraenoic acid from arachidonic acid via a P-450 enzyme (269). 20-Hydroxyeicosatetraenoic acid is a potent vasoconstricAn inward rectifier potassium current has been described in cerebral blood vessels (172, 292, 582, 668) . In tor that may produce this effect, at least in part, by inhibition of activity of calcium-dependent potassium channels contrast to calcium-dependent and voltage-dependent potassium channels, inward-rectifier potassium channels are in cerebral vascular muscle (269).
opened by membrane hyperpolarization (582) . These potassium channels normally conduct an outward hyperpo-C. Voltage-Dependent Potassium Channels larizing current and may play an important role in maintaining resting membrane potential. Inward-rectifier potassium channels are very sensitive to and are inhibited Voltage-dependent potassium channels (also known as delayed rectifier potassium channels) have been de-selectively by relatively low concentrations of extracellular barium ions (582) . Barium has inhibitory effects on scribed in cerebral vascular muscle (72, 393, 582). Like calcium-dependent potassium channels, the open proba-other potassium channels, but these effects occur at much higher concentrations than those required to inhibit inbility of voltage-dependent potassium channels increases with membrane depolarization (582) . When cells are depo-ward-rectifier potassium channels (582) .
Relatively little is known regarding the functional siglarized, these potassium channels are activated, resulting in an outward current that returns the membrane poten-nificance of inward-rectifier potassium channels in cerebral vessels. Recent findings suggest that inward-rectifier tial toward the resting level (582) . Thus voltage-dependent potassium channels appear to be a negative-feedback sys-potassium channels may play an important role in mediation of vasodilatation in response to extracellular potastem, like calcium-dependent potassium channels, which modulates vascular tone. A voltage-dependent potassium sium (172, 394, 668) . Small elevations in the concentration of extracellular potassium ion produce hyperpolarization channel that is expressed in vascular muscle has been cloned (619) .
and relaxation of cerebral arteries in vitro (394). Both
12-02-97 15:50:37 pra APS-Phys Rev effects are inhibited by relatively low concentrations of chronic hypertension indicates that the impairment extends beyond the receptor level (48, 843, 845). The conbarium ion, but not by a combination of TEA, glibenclamide, and 4-aminopyridine, suggesting that the response is cept that normal endothelial function is protective in cerebral vessels is supported by a recent genetic analysis demmediated by an inward-rectifier potassium channel (394). This mechanism is potentially important because modest onstrating cosegregation of impaired endotheliumdependent relaxation and stroke-prone phenotype (795). increases in the concentration of extracellular potassium ion, such as those that might occur during neuronal activaIn contrast to endothelium-dependent stimuli, cerebral vasodilatation in response to the endothelium-indetion, produce marked dilatation of cerebral blood vessels in vivo (231, 432, 515 HYPERTENSION during chronic hypertension, which suggests that impairment of vascular function is at the level of endothelium and not smooth muscle. Endothelial dysfunction may con-A. Acute Hypertension tribute to enhanced serotonin-induced constriction, which has been observed in large cerebral arteries of SHRSP Acute hypertension produces morphological evi- (506) . dence of damage to endothelium and impairs dilator reSeveral studies have attempted to define mechanisms sponses of cerebral blood vessels to endothelium-depenthat account for impaired endothelium-dependent relaxdent stimuli such as acetylcholine. This impairment can ation in cerebral blood vessels during chronic hypertenoccur after acute hypertension produced by systemically sion. The impairment appears to be reversible, because administered pressor agents (814) or experimentally inantihypertensive treatment restores endothelium-dependuced head injury (179, 411). Impaired responses to acedent responses to normal (843) . In the aorta of SHR, imtylcholine appear to be specific for endothelium, because paired endothelium-dependent relaxation is associated vasodilator responses to nitroprusside were relatively with increased expression of COX-1 (242). This enhanced normal in this model (179).
activity results in production of a COX-derived EDCF Mechanisms that cause impairment of cerebral arteri-(468) that counteracts the normal vasodilator effect of oles to endothelium-dependent stimuli may involve pro-EDRF (Fig. 4) . This same mechanism seems to account duction of reactive oxygen species. Production of superfor altered responses in cerebral arterioles during chronic oxide anion in brain has been measured in response to hypertension, because impaired endothelium-dependent acute hypertension (814) and fluid percussion injury (410, responses can be restored to normal using indomethacin 411, 765). Local application of superoxide dismutase or (510) or an inhibitor of PGH 2 /thromboxane A 2 receptors deferoxamine restores vasodilator responses to acetyl-(497) (Fig. 4) . choline toward normal, suggesting that inactivation of NO Impaired endothelium-dependent relaxation of the by superoxide anion or hydroxyl radical accounts for imbasilar artery, in contrast to cerebral arterioles, does not paired endothelial function (411, 814) (Fig. 4) . Experiappear to be due to production of a COX-derived conments examining effects of acute hypertension on vascutracting factor because indomethacin does not improve lar responses to acetylcholine by Kontos, Wei, and coresponses to endothelium-dependent agonists (386, 494). workers (814) were important because they provided the Impaired endothelium-dependent responses of the basilar first evidence that superoxide anion inactivates EDRF in artery during chronic hypertension could potentially be vivo.
due to reduced production or activity of EDRF. The finding that acute treatment with L-arginine, the substrate for B. Chronic Hypertension NO synthase, restores responses of the basilar artery to acetylcholine toward normal in older SHRSP provides some evidence to support this possibility (386). Endothelium-dependent relaxation is impaired in peripheral blood vessels in experimental animals and huIn contrast to agonist-induced endothelium-dependent relaxation, basal release of EDRF does not appear mans with chronic hypertension (242, 468, 624, 787, 854). Similarly, we and others have shown that dilatation of the to be impaired during chronic hypertension. This conclusion is based on the findings that inhibitors of NO synthase basilar artery (386, 391, 494), middle cerebral artery (781) , and cerebral arterioles (48, 497, 509, 510, 678, 843-845) produce similar constriction of cerebral arteries (391) and similar reductions in cerebral blood flow (336, 842) in in response to endothelium-dependent agonists including acetylcholine, methacholine, bradykinin, and ADP is im-SHRSP, SHR, and normotensive Wistar-Kyoto rats (WKY).
The functional influence of potassium channels in paired in spontaneously hypertensive rats (SHR) and stroke-prone SHR (SHRSP). The finding that cerebral va-cerebral vessels is altered during chronic hypertension.
Cerebral vasodilatation in response to activators of ATPsodilatation in response to A-23187 is also impaired during P14-7 / 9j07$$ja02
12-02-97 15:50:37 pra APS-Phys Rev sensitive potassium channels is impaired in SHRSP (389, formed in endothelium and macrophages in atherosclerotic lesions (7, 54, 98). Superoxide dismutase improves 752). Preliminary studies suggest that a high-salt diet impairs membrane hyperpolarization and relaxation of the endothelium-dependent relaxation during atherosclerosis (560, 748, 819) . In addition, plasma levels of ADMA, an middle cerebral artery in response to prostacyclin and hypoxia in vitro (460) . Relaxation of the middle cerebral endogenous inhibitor of NO synthase, are increased during hypercholesterolemia and might contribute to impairartery to both stimuli is inhibited by glibenclamide and thus appears to be mediated by activation of the ATP-ment of endothelium-dependent responses (66, 839, 851) .
Several studies suggest that administration of L-arginine, sensitive potassium channel (226) . Impaired cerebral vascular responses to an activator of ATP-sensitive potas-the substrate for NO synthase, improves endothelium-dependent relaxation during hypercholesterolemia and athsium channels in SHRSP can be restored largely to normal by chronic antihypertensive therapy (752) .
erosclerosis (125, 139, 147, 163). Recent evidence suggests that supplementation with tetrahydrobiopterin, an essenIn contrast, activity of calcium-dependent potassium channels appears to be enhanced during chronic hyper-tial cofactor for NO synthase, also improves endotheliumdependent relaxation using hypercholesterolemia (742) . tension. Efflux of 86 Rb, which is an index of potassium channel activity, is greater in carotid arteries from SHR Reductions in plasma cholesterol levels, which produce regression of atherosclerosis, restore endothelium-depenthan from WKY (33). Inhibitors of calcium-dependent potassium channels produce greater contraction of the ca-dent relaxation toward normal (252, 270, 449, 603) .
Recent studies have examined whether gene expresrotid artery in vitro (33) and the basilar artery in vivo (637) in chronically hypertensive rats, suggesting that activity of sion for endothelial NO synthase is altered during atherosclerosis. Oxidized low-density lipoprotein and lysophoscalcium-activated potassium is enhanced during chronic hypertension. Thus, in contrast to ATP-sensitive potas-phatidylcholine (a lipid component unique to oxidized low-density lipoprotein) impair endothelium-dependent sium channels, which appear to have reduced activity, calcium-dependent potassium channels appear to be acti-relaxation (20, 145, 722). Lysophophatidylcholine also impairs responses that are mediated by EDHF (233). Lowvated during chronic hypertension, presumably to compensate for increased intracellular calcium and enhanced density lipoprotein has been reported to both increase (289) and decrease (452) expression of NO synthase in myogenic tone. endothelium in culture. Importantly, mRNA and protein for endothelial NO synthase in the vessel wall are in-VII. HYPERCHOLESTEROLEMIA creased in atherosclerotic rabbits (356) . Recent evidence AND ATHEROSCLEROSIS also suggests that inducible NO synthase is expressed in the vessel wall in atherosclerotic arteries (98). Expression of inducible NO synthase may contribute to formation of Endothelium-dependent relaxation of noncerebral arteries is impaired in experimental animals and humans peroxynitrite during atherosclerosis (98).
Effects of atherosclerosis on endothelium-dependent with hypercholesterolemia and atherosclerosis (67, 73-75, 107, 119, 121, 138, 139, 146, 163, 227, 252, 451, 467 , responses of cerebral vessels are less clear. Impairment of endothelium-dependent relaxation is observed in the 669). Production or activity of EDRF under basal conditions and in response to endothelium-dependent agonists atherosclerotic carotid artery (205, 355, 384, 723, 730) .
Impaired endothelium-dependent relaxation of the carotid are both impaired. Some studies suggest that hypercholesterolemia alone, in the absence of atherosclerotic lesions, artery can be restored toward normal during regression of atherosclerosis (205, 730) . In comparison with the carotid is sufficient to produce endothelial dysfunction (107, 121, 252, 602, 749). Vasorelaxation in response to endothelium-artery, intracranial vessels appear to be resistant to development of atherosclerosis (355) . Relaxation of cerebral independent stimuli, such as nitrovasodilators, is generally intact in atherosclerotic arteries. One exception is vessels to endothelium-dependent stimuli can be normal in the same atherosclerotic animals that exhibit marked relaxation of the carotid artery to severe hypoxia, which is endothelium independent but nevertheless impaired in impairment of endothelium-dependent relaxation in the carotid artery and aorta (355, 384, 723) . In contrast, some atherosclerotic rabbits (749) .
Mechanisms that account for impaired endothelium-studies suggest that atherosclerosis or hypercholesterolemia produces endothelial dysfunction in cerebral arterdependent relaxation during atherosclerosis have not been completely defined, but probably involve generation ies. Oxidized low-density lipoprotein has been reported to impair relaxation of the basilar artery in response to of reactive oxygen species that inactivate EDRF (67, 372) (Fig. 4) . Several studies have demonstrated that vascular acetylcholine in vitro (349) . Hypercholesterolemia is reportedly associated with impaired endothelium-depenproduction of superoxide anion is increased during hypercholesterolemia and atherosclerosis (68, 559, 602, 603) . dent relaxation of the basilar artery to acetylcholine and ADP (690, 717). In hypercholesterolemic rabbits, adminisImmunocytochemistry suggests that peroxynitrite, the reaction product of superoxide anion and NO (Fig. 2) , is tration of L-arginine restored dilator responses of the ba-P14-7 / 9j07$$ja02
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botic activity in the carotid artery and produces increases in platelet-mediated vasoconstriction (447). In humans, The interaction of platelets and leukocytes with the vessel wall is altered during atherosclerosis (788) . For moderate hyperhomocysteinemia is associated with impaired endothelium-dependent relaxation in the forearm example, constrictor responses of coronary arteries in response to serotonin, which is released by platelets dur- (759) . Thus, in addition to hyperlipidemia, hyperhomocysteinemia may contribute to cerebral vascular dysfunction. ing aggregation, are greatly enhanced in patients with coronary artery disease (251, 518). Similarly, constriction of large cerebral arteries and blood vessels supplying the VIII. DIABETES eye in response to serotonin and thromboxane (also released by platelets) and in response to activation of platelets in vivo with collagen is enhanced by atherosclerosis Diabetes is associated with endothelial dysfunction in extracranial blood vessels in experimental animals (189, 202, 210, 279, 730, 753, 823) . Contraction of human middle cerebral arteries in response to platelets and leu-(157, 274, 437, 542, 655, 760) and humans (345, 521, 663, 694) . Similarly, impaired dilatation of cerebral arterioles kocytes in vitro is enhanced in vessels with atherosclerotic lesions (9). Because NO normally inhibits responses (493, 512, 641) and the basilar artery (230, 408, 496, 505) has been observed during diabetes mellitus. Increases in of cerebral arteries to serotonin and other vasoconstrictors (198, 771) , impairment of release or activity of NO cerebral blood flow in response to activation of muscarinic receptors are also impaired during diabetes (642). may contribute to augmented vasoconstrictor responses during atherosclerosis. Inactivation of NO by leukocytes
Mechanisms that mediate endothelial cell dysfunction during diabetes are not completely defined. Some is enhanced in leukocytes obtained from patients with carotid atherosclerosis as compared with leukocytes ob-evidence suggests that production of endothelium-derived NO is normal during diabetes (437, 655) . A recent study tained from control patients (10). In addition to impaired endothelial function, augmented vasoconstrictor re-reported that hyperglycemia does not alter levels of endothelial NO synthase mRNA, protein, or enzyme activity in sponses to serotonin during atherosclerosis may be mediated by increased activity of protein kinase C or changes endothelium (481) . Under these conditions, endotheliumdependent relaxation may be impaired by excess generain expression of serotonin receptor subtypes in vascular muscle (538, 747). Augmented constrictor responses of tion of reactive oxygen species that destroy NO (157, 274, 760, 761). Levels of mRNA for Mn-superoxide dismutase large cerebral arteries to serotonin are restored largely to normal during regression of atherosclerosis (279).
and Cu/Zn-superoxide dismutase in aorta have been reported to be decreased during diabetes (353) . Preliminary Atherosclerosis enhances constriction of large cerebral arteries and blood vessels supplying the eye in re-findings suggest that mRNA for COX-1 in aorta is also decreased during diabetes (100). sponse to activation of leukocytes in vivo (202) . Activated leukocytes can release several vasoactive substances that Impairment of endothelium-dependent relaxation during diabetes may also be due to simultaneous producmay contribute to augmented cerebral vasoconstrictor during atherosclerosis, including reactive oxygen species, tion of an EDCF (129, 760). In cerebral arterioles, activation of protein kinase C (641) and/or production of an thromboxane, leukotrienes, platelet-activating factor, and endothelin (13).
EDCF that activates a PGH 2 /thromboxane A 2 receptor (512) appears to account for endothelial dysfunction durIncreases in plasma levels of homocysteine, produced by either genetic or dietary factors, are associated ing diabetes (Fig. 4) . Hyperglycemia per se produces impairment of endothelium-dependent dilatation of cerebral with increased risk for complications of atherosclerosis (492, 517) . Severe hyperhomocysteinemia predisposes to arterioles, which also seems to involve activation of protein kinase C (511). In contrast to cerebral arterioles, imvenous and arterial thrombosis, and moderate hyperhomocysteinemia has been proposed to be an independent paired responses to endothelium-dependent stimuli in the basilar artery are not due to production of an COX-derived risk factor for peripheral vascular disease, myocardial infarction, and stroke (62, 517, 646) . Furchgott and co-work-EDCF (496) and are not improved by acute treatment with L-arginine (505), the substrate for NO synthase. ers (343) provided evidence that acute exposure to high levels of homocysteine (100 mM) impairs endotheliumDiabetes mellitus is not associated with generalized impairment of vasodilator mechanisms. Cerebral vasodidependent relaxation of the aorta in vitro by a mechanism that involves generation of superoxide anion. Preliminary latation in response to several endothelium-independent stimuli including nitroglycerin, nitroprusside, and forevidence suggests that high levels of homocysteine, in the presence of Cu 2/ , impair endothelium-dependent re-skolin is normal during diabetes, indicating that nonspecific impairment of vascular muscle is not present (230, sponses in the cerebral circulation via a mechanism that also involves generation of superoxide anion (858). A re-493, 496, 499-501, 505, 507) . In contrast, cerebral vasodila-
12-02-97 15:50:37 pra APS-Phys Rev tation in response to some stimuli that act directly on stem in response to activators of ATP-sensitive potassium channels was impaired in old rats (770). Impairment of vascular muscle is impaired during diabetes. This impairment includes responses to isoproterenol and norepineph-vasoconstrictor responses to several stimuli has been reported in the human basilar artery (272). rine (via activation of b-adrenergic receptors) (500, 501, 641) as well as activators of ATP-sensitive potassium channels (499, 507) .
X. ISCHEMIA
IX. AGING
Ischemia can impair responses of cerebral blood vessels to several stimuli. Dilatation of cerebral arterioles in response to the endothelium-dependent agonist acetylNormal aging is associated with several changes in cardiovascular function and is sometimes associated with choline is impaired after ischemia with reperfusion (123, 126, 503, 578). Formation of reactive oxygen species inimpairment of endothelium-dependent responses (246, 482, 772) . Relaxation of the basilar artery from humans cluding superoxide anion, which is known to occur during reperfusion after ischemia (29, 578), seems to mediate (271) and cerebral arterioles (508) and the carotid artery (635) in rats in response to endothelium-dependent ago-impaired endothelium-dependent relaxation in cerebral arterioles (578) (Fig. 4) because impaired vasodilatation nists is impaired with aging.
In contrast to changes that occur during chronic hy-can be restored toward normal with superoxide dismutase and catalase (578). pertension and diabetes mellitus, impaired dilatation of cerebral arterioles in response to endothelium-dependent There is potentially more than one source of reactive oxygen species during reperfusion after ischemia. Superstimuli during aging does not appear to be related to the production of a COX-derived EDCF (508) . Direct measure-oxide anion may be generated through the COX pathway (29, 578) or by NO synthase in the absence of adequate ments indicate that release of NO in response to endothelium-dependent stimuli is impaired in the aorta, but not levels of L-arginine (149, 194, 830) . Expression of both COX-1 and COX-2 has been reported to increase in rethe pulmonary artery (772). Bioassay studies suggest that luminal release of NO from the carotid artery is not im-sponse to ischemia with reperfusion (296, 656). Increased production of NO in combination with superoxide anion paired with aging, although the artery itself does not relax normally to acetylcholine (635) . These findings have led may result in formation of peroxynitrite, which produces vasodilatation but may also produce vascular injury (791) to the suggestion that impaired endothelium-dependent relaxation may be due to generation of reactive oxygen (Fig. 2) . Cerebral endothelium in culture produces hydroxyl radical in response to anoxia (430) and thus is species in the vessel wall (635) (Fig. 4) .
Deposits of b-amyloid in brain and cerebral vessels also a potential source of reactive oxygen species during ischemia. are seen in aging individuals and in Alzheimer's disease patients. Recent data suggest that b-amyloid may impair Brain injury during reperfusion after ischemia is associated with activation of leukocytes and adherence of leuendothelium-dependent relaxation by generation of superoxide anion (763). b-Amyloid produces oxidative stress kocytes to endothelium (13). Intercellular adhesion molecule-1 (ICAM-1), an important mediator of leukocyte adin cerebral endothelium and neurons via an effect mediated by receptors for advanced glycation end products hesion (450), is expressed in cerebral endothelium in response to ischemia (136, 220, 608). Studies using mice (838) . Expression of these receptors is enhanced in cerebral vessels during Alzheimer's disease (838) . Thus the that are deficient in expression of the gene for ICAM-1 suggest that neutrophils invade and accumulate in ischpresence of b-amyloid protein near cerebral vessels may contribute to impairment of endothelium-dependent re-emic tissue, and these accumulating cells contribute to injury of the brain and possibly vessels (136, 735). Invadsponses that occurs with aging. In transgenic mice that overexpress amyloid precursor protein, preliminary stud-ing leukocytes may be a source of reactive oxygen species and may express inducible NO synthase (13, 317, 320). ies suggest cerebral vasodilatation in response to acetylcholine is impaired (856). Inducible NO synthase has been Leukocytes can also impair endothelium-dependent relaxation of cerebral arteries (8, 11, 13) through a mechanism detected in cerebral microvessels during Alzheimer's disease (162), and b-amyloid has been reported to enhance that may involve platelet-activating factor (11, 12).
Several lines of evidence, including the use of mice expression of inducible NO synthase in response to proinflammatory cytokines (689) .
that are deficient in expression of the genes for endothelial and neuronal NO synthase, suggest that NO produced Relaxation of cerebral vessels in response to nitroprusside and activators of ATP-sensitive potassium chan-by NO synthase in endothelium plays a protective role during and after cerebral ischemia (308, 309, 459, 552, nels is not altered with aging (201, 271, 482, 635, 770) , with the exception of one study in which dilatation of the 623, 857, 859). Endothelium-derived NO may be protective against ischemia by contributing to vasodilatation and by basilar artery and cerebral arterioles that supply brain P14-7 / 9j07$$ja02
12-02-97 15:50:37 pra APS-Phys Rev inhibition of aggregation and adherence of platelets or hemorrhage (171, 299, 354, 364, 377-379, 732, 794, 836) and in the basilar artery from patients after subarachnoid hemorleukocytes (194, 462, 829) . The recent finding that physiological concentrations of peroxynitrite inhibit interaction rhage (273, 612). Several mechanisms have been proposed to account for this vascular dysfunction. One possibility is of endothelium and leukocytes raises the possibility that a portion of the protective effect of endothelium-derived that subarachnoid hemorrhage causes a reduction in production or activity of NO. Levels of NO synthase in endothe-NO during ischemia (or other situations in which superoxide is generated) relates to its inactivation of superoxide lium (determined by Western blotting) and activity of NO synthase in large cerebral arteries have been reported to be and perhaps inhibition of leukocyte adhesion by physiological concentrations of peroxynitrite (444).
relatively unchanged after subarachnoid hemorrhage (360, 577) . In addition, release of NO (detected using a bioassay Immunocytochemical analysis of protein levels suggests that expression of the gene for NO synthase (NOS system) has been reported to be normal after subarachnoid hemorrhage (377, 378). In contrast, another study suggests III) is upregulated in cerebral endothelium in response to cerebral ischemia (863) . Measurements of calcium-inde-that mRNA for endothelial NO synthase is decreased in cerebral vessels undergoing vasospasm after subarachnoid hempendent enzyme activity and immunocytochemistry suggest that inducible NO synthase is expressed in cerebral orrhage (287).
A second possibility is that activation of soluble guamicrovessels in response to ischemia (317, 567, 568). Mice that lack expression of inducible NO synthase are resis-nylate cyclase and production of cGMP are abnormal after subarachnoid hemorrhage (377, 378, 612, 732). Impaired tant to focal cerebral ischemia (318, 319). Overall, it is not clear whether vascular expression of inducible NO relaxation of cerebral arteries to NO and nitrovasodilators has been observed in some (377, 378, 612, 732) but not synthase is beneficial or detrimental.
Cerebral ischemia may also impair responses of cere-all studies (273, 354, 836) after subarachnoid hemorrhage. Levels of protein (360) and activity of soluble guanylate bral vessels to activation of ATP-sensitive potassium channels. For example, dilatation of cerebral arterioles cyclase (the primary target for EDRF in vascular muscle), as well as cGMP levels (573, 591, 592), are reduced in a in response to CGRP and prostacyclin, which produce glibenclamide-sensitive dilatation of cerebral vessels (41, canine and primate models of subarachnoid hemorrhage.
Reduced levels of protein and impaired activity of soluble 297, 388, 463), and aprikalim (an activator of ATP-sensitive potassium channels; Fig. 6 ) is impaired after ischemia guanylate cyclase may be specific because cerebral vasodilatation in response to brain natriuretic peptide (which with reperfusion (41, 463).
In addition to NO, production of other vasoactive activates particulate guanylate cyclase) is normal after experimental subarachnoid hemorrhage (732). Although products may change in response to ischemia. Levels of endothelin in brain tissue (42, 792, 837) and brain extracel-some studies indicate that the soluble guanylate cyclase/ cGMP system is impaired, intracarotid infusion of NO relular fluid (42) are increased after ischemia, and increased production of endothelin may contribute to brain injury verses vasospasm after subarachnoid hemorrhage in nonhuman primates (3). and limit vasodilatation in response to ischemia (632) . A combined ET A /ET B receptor antagonist protects against A third possibility relates to effects of hemoglobin on NO. Hemoglobin avidly binds NO, and thus the presence neuronal injury after cerebral ischemia (604). Gene expression of adrenomedullin is also increased in response of hemoglobin may contribute to vasospasm after subarachnoid hemorrhage by preventing the diffusion of NO, to ischemia (802). It is not known whether enhanced production of adrenomedullin, a potent vasodilator (43, 436), produced under basal conditions by endothelium, to smooth muscle. In addition, hemoglobin may also destroy plays a protective role during cerebral ischemia.
NO by generation of superoxide anion (473, 474) (Fig.  4) . A recent study reported that local administration of XI. SUBARACHNOID HEMORRHAGE superoxide dismutase reduced the magnitude of cerebral vasospasm, which is consistent with the hypothesis that excess generation of oxygen radicals contributes to vaso-A. Endothelium-Dependent Relaxation spasm after subarachnoid hemorrhage (351) . Leukocytes can impair endothelium-dependent relaxSubarachnoid hemorrhage is often associated with cerebral vasospasm and, as a consequence, stroke (137, ation of cerebral arteries (8, 13, 148), and adherence and infiltration of leukocytes in cerebral arteries are initiated 221). Several mechanisms may contribute to vasospasm after subarachnoid hemorrhage including impaired endo-after subarachnoid hemorrhage (13, 262). Subarachnoid hemorrhage is associated with enhanced expression in thelium-dependent relaxation, production of EDCFs including endothelin, and impaired activity of potassium the basilar artery of ICAM-1, which promotes adhesion of leukocytes (263). Thus several mechanisms may contribchannels in cerebral blood vessels.
Endothelium-dependent relaxation is impaired in large ute to impairment of endothelium-dependent relaxation of cerebral arteries after subarachnoid hemorrhage. cerebral arteries in experimental models of subarachnoid P14-7 / 9j07$$ja02
12-02-97 15:50:37 pra APS-Phys Rev B. Endothelin changes in activity of potassium channels in cerebral vessels. Cerebral vascular muscle is depolarized after subIn addition to impaired endothelial production of NO, arachnoid hemorrhage, and this depolarization probably recent observations suggest that endothelial production contributes to vasoconstriction and perhaps vasospasm of endothelin may be a major mechanism that contributes (268, 805, 867). Depolarization of vascular muscle after to vasospasm after subarachnoid hemorrhage. As dis-subarachnoid hemorrhage is most likely due to inhibition cussed in section IIID, endothelin is a potent constrictor of potassium channels (268). Nicorandil, which produces of cerebral arteries that normally produces vasoconstric-relaxation of cerebral vessels in part by activation of potion by activation of ET A receptors (1, 2, 154, 212, 217, tassium channels (332), partially reverses vasospasm in an 350, 390, 586, 647, 695, 701, 820, 869) (Fig. 3) . Levels of experimental model of subarachnoid hemorrhage (268). ET-1 are increased in the basilar artery and in cerebrospi-Recent studies suggest that, although several dilator nal fluid after subarachnoid hemorrhage (291, 397, 399, mechanisms are impaired after subarachnoid hemor-424, 488, 691, 744, 866). Several studies in experimental rhage, dilatation of the basilar artery in response to activaanimals, including nonhuman primates, suggest that vaso-tors of potassium channels is preserved or enhanced after spasm after experimental subarachnoid hemorrhage can subarachnoid hemorrhage (731, 732, 867). Dilatation of be significantly attenuated by antagonists of ET A recep-the large cerebral arteries in response to synthetic activators such as BQ-123 (223, 288, 291, 333, 334, 376, 587, 820, tors of potassium channels (aprikalim and cromakalim) 835) or combined ET A /ET B receptor antagonists (691, 716, and CGRP (which hyperpolarizes cerebral vascular mus-820, 866, 868, 870). Endothelin-1 is produced from its pre-cle) (392, 696) is preserved or enhanced after experimencursor, big ET-1, by ECE (692, 833). Phosphoramidon and tal subarachnoid hemorrhage (6, 167, 300, 325, 329, 731, CGS-26303, inhibitors of ECE (103, 692, 833), attenuate 732, 867). These findings suggest that activators of potasvasospasm after subarachnoid hemorrhage (490). Anti-sium channels in vascular muscle may have beneficial sense oligonucleotides for prepro-ET-1 mRNA inhibit con-effects during vasospasm after subarachnoid hemorrhage. traction of the basilar artery in response to hemolysate (611).
In addition to the ET-1 gene, expression of other ET-1-XII. MENINGITIS related genes appears to change after subarachnoid hemorrhage. Levels of mRNA for ET A receptors are increased Brain inflammation and bacterial infections of the in cerebral arteries after subarachnoid hemorrhage (333). central nervous system (meningitis) are associated with In normal cerebral arteries, both functional studies (1, 2, dilatation of cerebral blood vessels and increases in cere-154, 212, 350, 390, 586, 695, 701, 820, 869) and competition bral blood flow (60, 260, 400-402, [650] [651] [652] 754) . Lipobinding analysis (691) suggest that contraction of cerebral polysaccharide and proinflammatory cytokines such as arteries to endothelin is mediated very predominantly by tumor necrosis factor-a cause cerebral vasodilatation (83, ET A receptors. Interestingly, ET B receptors are expressed 85, 86, 714) and probably contribute to these vascular to a greater extent, presumably in vascular muscle, after changes. Some of the pathophysiological changes that ocsubarachnoid hemorrhage (286, 691). Augmented expres-cur during meningitis include brain edema and increases sion of ET B receptors in vascular muscle may contribute in intracranial pressure (400, 401) . to vasoconstriction that occurs with subarachnoid hemorRecent studies have provided insight into mecharhage (691) (Fig. 3) . Activity of ECE in the basilar artery nisms that produce cerebral vasodilation in the early also increases threefold after subarachnoid hemorrhage phase of meningitis. One mechanism may involve expres-(691), which may also contribute to vasospasm. sion of inducible NO synthase (Fig. 5) . The level of nitrite Stimuli that cause endothelin gene expression after in cerebrospinal fluid is increased markedly in patients subarachnoid hemorrhage are not well defined. Candi-and experimental animals with meningitis (97, 419, 532, dates include hemoglobin and thrombin, factors which 649, 786, 793). Messenger RNA for inducible NO synthase are known to enhance endothelin gene expression in en-has been detected in brain during viral meningitis but dothelium (128, 605, 692, 745) , and are present in the seems to be confined primarily to inflammatory cell infilthrombus and cerebrospinal fluid after subarachnoid hem-trates (101). Cerebral endothelium produces nitrite in reorrhage. Leukocytes, which infiltrate the basilar artery sponse to pneumococcal stimulation (401) , and increases after subarachnoid hemorrhage, are immunoreactive for in cerebral blood flow that occur early in the pathogenesis ET-1 (399) and thus represent another potential source of of bacterial meningitis are mediated by NO (260, 401, 724). endothelin.
Stimuli that could cause expression of inducible NO synthase in brain during meningitis include cell wall com-C. Potassium Channels ponents of bacteria, including lipopolysaccharide, local production of tumor necrosis factor-a or interleukin-1b, A third major mechanism that may contribute to vasospasm after subarachnoid hemorrhage involves and reactive oxygen species (650, 652) . Increased produc-P14-7 / 9j07$$ja02
12-02-97 15:50:37 pra APS-Phys Rev tion of superoxide anion has been observed in brain and Because adrenomedullin can act via stimulation of receptors for CGRP (666) , it is possible that cerebral vasoalong cerebral microvessels during experimental meningitis (520, 446) . Pneumococcal cell wall components in-dilatation in response to lipopolysaccharide that is inhibited by a CGRP antagonist is mediated, in part, by crease production of nitrite and tumor necrosis factor-a in astrocytes and endothelium in culture (61, 228, 400) , adrenomedullin.
Although some laboratories have had difficulty demwhich are inhibited by L-NNA, aminoguanidine, dexamethosone, and interleukin-10 (61, 228, 400). Tumor necrosis onstrating expression of inducible NO synthase in human monocytes or macrophages, the gene for inducible NO factor-a and interferon-g cause expression of inducible NO synthase in cerebral endothelium (561) .
synthase can be expressed under some conditions in these human cells (164, 584) . In brain, inducible NO synthase Leukocytes enter the subarachnoid space and cerebrospinal fluid early in the development of meningitis and is expressed in microglia (a monocyte/macrophage-like cell) during multiple sclerosis in humans (39). Immunocymay contribute to its pathophysiology. Expression of adhesion molecules is critical for accumulation of leuko-tochemical evidence suggests that peroxynitrite is also formed in the brain in multiple sclerosis (39). cytes at sites of bacterial infection (182) , and recruitment of leukocytes contributes to development of brain edema and increases in cerebral blood flow (21). Because leuko-XIII. CONCLUSIONS AND FUTURE DIRECTIONS cytes can express inducible NO synthase, it is possible that attachment and migration of these cells contribute to increases in permeability of the blood-brain barrier and
In summary, there have been many advances in our understanding of cerebral vascular biology and pathovasodilatation during meningitis (69, 70, 97, 721). Inhibition of adhesion molecules reduces leukocyte rolling and physiology in recent years. These advances include demonstration of major roles for both endothelium and potasinflammation in experimental meningitis (21, 808). Interleukin-10 inhibits increases in cerebral blood flow, in-sium channels in regulation of cerebral vascular tone.
These mechanism can be altered, often in a selective mantracranial pressure, and leukocyte migration into cerebral spinal fluid during meningitis (400) . Influx of leukocytes ner, under pathophysiological conditions. Additional insight in cerebral vascular biology in the and disruption of the blood-brain barrier in response to tumor necrosis factor-a and interleukin-1b are reduced future may be possible with incorporation of molecular approaches in studies of cerebral vessels. Although these in mice that are deficient in expression of leukocyte adhesion molecules (756) .
approaches have been used to only a limited extent to date, molecular biological methods offer considerable In addition to expression of inducible NO synthase, other mechanisms may contribute to cerebral vasodilata-promise for providing new insight in studies of the cerebral circulation. tion during meningitis or in response to proinflammatory cytokines. For example, many of the same stimuli that A potentially valuable approach is the study of animal models that are deficient in expression of specific genes produce expression of inducible NO synthase also cause expression of COX-2 (537, 828), and expression of COX-(gene knockouts). Gene mutation approaches have been advanced recently to include the possibility of inducible 2 is considered to be important in inflammation (537, 828). Activation of trigeminal C fibers (807), receptors for CGRP knockouts and cell-specific targeting. An alternative approach to examine the role of specific genes is to inhibit (86), and substance P (653) may also contribute to cerebral vasodilatation in response to lipopolysaccharide or gene expression using antisense oligonucleotides or oligonucleotides that inhibit availability of transcription factors during meningitis. Lipopolysaccharide may cause stimulation of trigeminal sensory fibers that release CGRP locally. that are necessary for gene expression.
Several murine models have been developed that are The observation that meningitis is commonly associated with headache is consistent with the possibility that tri-deficient in expression of genes that are important for vascular biology, including neuronal NO synthase (305, geminal fibers are activated. In addition, recent findings suggest that activation of receptors for bradykinin also 308, 330, 623), endothelial NO synthase (307, 309, 713), and inducible NO synthase (438, 475, 816) . Mice that are contributes to increases in cerebral blood flow and brain edema during meningitis (461) .
doubly mutant in endothelial and neuronal NO synthase have also been produced (733). Such models may prove It is also possible that adrenomedullin, produced in response to lipopolysaccharide, contributes to vasodilata-valuable for several reasons. First, although inhibitors of NO synthase have been very useful in providing insight tion during meningitis. The peptide adrenomedullin is structurally related to CGRP (666) . Adrenomedullin is pro-into the role of NO in the cerebral circulation, many of these inhibitors are not completely selective for a single duced in both endothelium and vascular muscle, and expression of the gene for adrenomedullin is enhanced isoform of NO synthase. Thus defining the role of a specific isoform of NO synthase can sometimes be difficult. by lipopolysaccharide (727). Adrenomedullin produces marked relaxation of cerebral blood vessels (436, 802) . One value of NO synthase mutants is that they allow stud-P14-7 / 9j07$$ja02
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